N-[(2S)-1-[(2S,4R,5R)-4-[4-[[(2S)-3-methoxy-2-methylpropoxy]methyl]phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-2-yl]propan-2-yl]acetamide

C42H59N3O8S — CID 67061763

IUPACN-[(2S)-1-[(2S,4R,5R)-4-[4-[[(2S)-3-methoxy-2-methylpropoxy]methyl]phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-2-yl]propan-2-yl]acetamide
SMILESCOCCCN1CCOc2ccc(CO[C@H]3CN(S(=O)(=O)c4ccc(C)cc4)[C@H](C[C@H](C)NC(C)=O)C[C@@H]3c3ccc(COC[C@@H](C)COC)cc3)cc21
InChIInChI=1S/C42H59N3O8S/c1-30-8-15-38(16-9-30)54(47,48)45-25-42(53-29-35-12-17-41-40(23-35)44(19-21-52-41)18-7-20-49-5)39(24-37(45)22-32(3)43-33(4)46)36-13-10-34(11-14-36)28-51-27-31(2)26-50-6/h8-17,23,31-32,37,39,42H,7,18-22,24-29H2,1-6H3,(H,43,46)/t31-,32-,37+,39+,42-/m0/s1
InChIKeyGGNFUXJTRQJROU-BBRGPIHYSA-N
MW766.01 g/mol
LogP6.08
Rot. Bonds19

About N-[(2S)-1-[(2S,4R,5R)-4-[4-[[(2S)-3-methoxy-2-methylpropoxy]methyl]phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-2-yl]propan-2-yl]acetamide

N-[(2S)-1-[(2S,4R,5R)-4-[4-[[(2S)-3-methoxy-2-methylpropoxy]methyl]phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-2-yl]propan-2-yl]acetamide (PubChem CID 67061763) has the molecular formula C42H59N3O8S and a molecular weight of 766.01 g/mol. Its IUPAC name is N-[(2S)-1-[(2S,4R,5R)-4-[4-[[(2S)-3-methoxy-2-methylpropoxy]methyl]phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-2-yl]propan-2-yl]acetamide.

Molecular Properties

Compound NameN-[(2S)-1-[(2S,4R,5R)-4-[4-[[(2S)-3-methoxy-2-methylpropoxy]methyl]phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-2-yl]propan-2-yl]acetamide
PubChem CID67061763
Molecular FormulaC42H59N3O8S
Molecular Weight766.01 g/mol
Exact Mass765.40
IUPAC NameN-[(2S)-1-[(2S,4R,5R)-4-[4-[[(2S)-3-methoxy-2-methylpropoxy]methyl]phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-2-yl]propan-2-yl]acetamide
SMILESCOCCCN1CCOc2ccc(CO[C@H]3CN(S(=O)(=O)c4ccc(C)cc4)[C@H](C[C@H](C)NC(C)=O)C[C@@H]3c3ccc(COC[C@@H](C)COC)cc3)cc21
InChIInChI=1S/C42H59N3O8S/c1-30-8-15-38(16-9-30)54(47,48)45-25-42(53-29-35-12-17-41-40(23-35)44(19-21-52-41)18-7-20-49-5)39(24-37(45)22-32(3)43-33(4)46)36-13-10-34(11-14-36)28-51-27-31(2)26-50-6/h8-17,23,31-32,37,39,42H,7,18-22,24-29H2,1-6H3,(H,43,46)/t31-,32-,37+,39+,42-/m0/s1
InChIKeyGGNFUXJTRQJROU-BBRGPIHYSA-N
XLogP6.08
TPSA115.87 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds19
Heavy Atoms54
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500766.01
LogP ≤ 56.08
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[(2S)-1-[(2S,4R,5R)-4-[4-[[(2S)-3-methoxy-2-methylpropoxy]methyl]phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-2-yl]propan-2-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(2S)-1-[(2S,4R,5R)-4-[4-[[(2S)-3-methoxy-2-methylpropoxy]methyl]phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-2-yl]propan-2-yl]acetamide?
The IUPAC name of N-[(2S)-1-[(2S,4R,5R)-4-[4-[[(2S)-3-methoxy-2-methylpropoxy]methyl]phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-2-yl]propan-2-yl]acetamide (CID 67061763) is N-[(2S)-1-[(2S,4R,5R)-4-[4-[[(2S)-3-methoxy-2-methylpropoxy]methyl]phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-2-yl]propan-2-yl]acetamide.
What is the SMILES notation for N-[(2S)-1-[(2S,4R,5R)-4-[4-[[(2S)-3-methoxy-2-methylpropoxy]methyl]phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-2-yl]propan-2-yl]acetamide?
The canonical SMILES for N-[(2S)-1-[(2S,4R,5R)-4-[4-[[(2S)-3-methoxy-2-methylpropoxy]methyl]phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-2-yl]propan-2-yl]acetamide is COCCCN1CCOc2ccc(CO[C@H]3CN(S(=O)(=O)c4ccc(C)cc4)[C@H](C[C@H](C)NC(C)=O)C[C@@H]3c3ccc(COC[C@@H](C)COC)cc3)cc21.
What is the InChIKey of N-[(2S)-1-[(2S,4R,5R)-4-[4-[[(2S)-3-methoxy-2-methylpropoxy]methyl]phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-2-yl]propan-2-yl]acetamide?
The InChIKey is GGNFUXJTRQJROU-BBRGPIHYSA-N. The full InChI is InChI=1S/C42H59N3O8S/c1-30-8-15-38(16-9-30)54(47,48)45-25-42(53-29-35-12-17-41-40(23-35)44(19-21-52-41)18-7-20-49-5)39(24-37(45)22-32(3)43-33(4)46)36-13-10-34(11-14-36)28-51-27-31(2)26-50-6/h8-17,23,31-32,37,39,42H,7,18-22,24-29H2,1-6H3,(H,43,46)/t31-,32-,37+,39+,42-/m0/s1.
What are the key properties of N-[(2S)-1-[(2S,4R,5R)-4-[4-[[(2S)-3-methoxy-2-methylpropoxy]methyl]phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-2-yl]propan-2-yl]acetamide?
N-[(2S)-1-[(2S,4R,5R)-4-[4-[[(2S)-3-methoxy-2-methylpropoxy]methyl]phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-2-yl]propan-2-yl]acetamide has a molecular weight of 766.01 g/mol, XLogP of 6.08, 19 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2S)-1-[(2S,4R,5R)-4-[4-[[(2S)-3-methoxy-2-methylpropoxy]methyl]phenyl]-5-[[4-(3-methoxypropyl)-2,3-dihydro-1,4-benzoxazin-6-yl]methoxy]-1-(4-methylphenyl)sulfonylpiperidin-2-yl]propan-2-yl]acetamide is sourced from PubChem (CID 67061763), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).